To access all features and enjoy the full functionality of this site, please ensure your browser is up-to-date. For IE8 users, the most recent version is IE11.

    BAERVELDTTM Glaucoma Implants

    BAERVELDTTM Glaucoma Implants

    baerveldt_logo.png

    Instructional Guides

    Instructional Guides

    Instructional Guides

    Easing the Pressure

    The BAERVELDTTM BG 103-250, BAERVELDTTM BG 101-350 and BAERVELDTTM Pars Plana BG 102-350 Glaucoma Implants

    Provide pressure control with a minimally invasive BAERVELDTTM Glaucoma Implant. Its fenestration system is designed to control bleb height and volume while a patented larger surface area enhances IOP control.1,2 When traditional glaucoma therapy can’t help the rising IOP, provide control with a BAERVELDTTM Glaucoma Implant.

    Large plate implants, such as BAERVELDTTM Implants, facilitate aqueous outflow to help provide IOP control.3

    • Allows improved aqueous filtration
    • Increases pressure relief

    BAERVELDTTM Implants only require single-quadrant insertion, allowing for better IOP control than competing implants.4,5

    The BAERVELDTTM Implants’ patented bleb control mechanism allows fibrotic tissue growth through the fenestrations in the plate, controlling bleb height and volume.2,6

    • Reduces the likelihood of ocular motility disturbances5
    • Helps ensure a low profile for better globe fit
     

    BAERVELDTTM BG 103-250 Glaucoma Implant7

    BAERVELDTTM BG 101-350 Glaucoma Implant7

    BAERVELDTTM Pars Plana BG 102-350 Glaucoma Implant7

    Surface Area:

    250 mm2

    350 mm2

    350 mm2

    Plate Length:

    22 mm

    32 mm

    32 mm

    Tube Length:

    32 mm

    32 mm

    7 mm

    Fenestrations:

    4

    4

    4

    Placement:

    Anterior chamber

    Anterior chamber

    Posterior chamber (Pars Plana)

    Drainage Mechanism:

    Open tube

    Open tube

    Open tube with Hoffman Elbow

    REFERENCES

    1. Gedde S, Schiffman J, Feuer W, et al. Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am J Ophthalmol.2007;143(1):9-22. REF2015OTH0534.
    2. Lloyd MA, Baerveldt G, Fellenbaum PS, et al. Intermediate-term results of a randomized clinical trial of the 350 - versus the 500 mm2 Baerveldt Implant. Ophthalmology. 1994;101(8):1456-1464. REF2014MLT0045.
    3. Gedde, S. et al. Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153(5):804-814. REF2021CT4234. 
    4. Heuer DK, Lloyd MA, Abrams DA, et al. Which is better? One or two? A randomized clinical trial of single-plate versus double-plate Molteno implantation for glaucomas in aphakia and pseudophakia. Ophthalmology. 1992;99(10):1512-1519. REF2014MLT0043.
    5. Fellenbaum PS, Sidoti P, Heuer DK, Minckler DS, Baerveldt G, Lee PP. Experience with the Baerveldt implant in young patients with complicated glaucomas. J Glaucoma. 1995;4(2):91-97. REF2015OTH0537.
    6. Hodkin MJ, Goldblatt WS, Burgoyne CF, Ball SF, Insler MS. Early clinical experience with the Baerveldt implant in complicated glaucomas. Am J Ophthalmol. 1995(1);120:32. REF2015OTH0535.
    7. Baerveldt Glaucoma Implant DfU - INT - Z310859, Rev. 02, July 2014. REF2015MLT0010.

     

     

    © Johnson & Johnson Surgical Vision, Inc. 2022.

    For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question.

    PP2022MLT4205